obinutuzumab,venetoclax,atezolizumab
roche,abbvie
['obinu', 'atezo', 'dlbcl', 'lymsm', 'venetoclax']
congress| #asco23 anna frustaci, niguarda cancer center, presents results from molto evaluating efficacy of atezolizumab, venetoclax &amp; obinutuzumab in patients with untreated dlbcl-rs. treatment was active in patients with dlbcl-rs and the study met it's primary endpoint #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm